> Reagents, Molecular Assay, Gene Anomaly, Mutation, EGFR
Reagents, Molecular Assay, Gene Anomaly, Mutation, EGFR
Definition : Molecular assay reagents intended to identify mutations in the epidermal growth factor receptor (EGFR) gene, located at chromosome 7p12.3-p12.1. Mutations at this locus have been identified in most patients with non-small-cell lung cancer and adenocarcinoma of the lung and may be associated with other carcinomas (e.g., glioblastoma).
Entry Terms : "Glioblastoma Gene Mutation Detection Reagents" , "Solid Tumor Cancer Gene Mutation Detection Reagents" , "EGFR Gene Mutation Detection Reagents"
UMDC code : 24390
Roche Molecular Systems Inc
Roche Molecular Diagnostics (RMD) is a business area of Roche Diagnostics (Basel, Switzerland) that develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies. With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD's clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.
Ventana Medical Systems Inc
Ventana Medical Systems, Inc., was launched in 1987 by a professor and practicing pathologist, Dr. Thomas Grogan. Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide.